4SC AG has expanded its collaboration with BioNTech AG with the signing of a research agreement to discover new compounds against cancer. The three-year agreement is being executed through 4SC’s wholly-owned research unit 4SC Discovery GmbH. ---Subscribe to MedNous to access this article--- Company News
